Amsterdam, Netherlands

Norgine Bv


USPTO Granted Patents = 23

% Expired Patents = 39.1



Trademarks = 1

Forward Citations = 46

Loading Chart...
Loading Chart...

49 inventors (with patents filed for the assignee):

goldMedal Marc Halphen (12 out of 12 patents)

silverMedal Alex Ungar (12 out of 12 patents)

bronzeMedal Alasdair Cockett (11 out of 11 patents)

4.  Peter Stein (11 out of 11 patents)

5.  Lucy Clayton (6 out of 6 patents)

6.  Mark Christodoulou (6 out of 6 patents)

7.  Ian Davidson (6 out of 6 patents)

8.  Lynn Farrag (6 out of 6 patents)

9.  Leighton Jones (6 out of 6 patents)

10.  Vanik Petrossian (6 out of 6 patents)

11.  David Tisi (6 out of 6 patents)

12.  Jeffrey Worthington (6 out of 6 patents)

13.  Ian David Cox (6 out of 8 patents)

14.  Hans-Jurgen Gruss (5 out of 5 patents)

15.  Robert Downham (4 out of 20 patents)


23 patents:

Norgine Bv is a European specialty pharmaceutical company headquartered in Amsterdam, focusing on the development and commercialization of innovative medicines. The company specializes in areas such as gastroenterology, hepatology, and critical care, aiming to address unmet medical needs through its advanced therapeutic solutions. With a commitment to improving patient outcomes, Norgine collaborates with healthcare professionals and stakeholders across Europe to deliver high-quality healthcare solutions tailored to specific patient populations.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Norgine Bv
23 Patents

#32 in Amsterdam

#311 in Netherlands

#27,619 in the World

Amsterdam, NL
Amsterdam, Netherlands
Forward Citations = 46

49 inventors:

Please report any incorrect information to [email protected]
Loading…